Bo Wu

发表

Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis

P. Christadoss, A. Lovett-racke, M. Racke, 2003, Journal of Neuroimmunology.

Experimental Autoimmune Myasthenia Gravis in the Mouse

P. Christadoss, E. Goluszko, E. Tüzün, 2011, Current protocols in immunology.

Experimental Autoimmune Myasthenia Gravis in the Mouse

P. Christadoss, E. Goluszko, E. Tüzün, 2011, Current protocols in immunology.

IFN-α treatment suppresses the development of experimental autoimmune myasthenia gravis

M. Shenoy, P. Christadoss, S. Baron, 1995 .

Circulating Immune Complexes Augment Severity of Antibody-Mediated Myasthenia Gravis in Hypogammaglobulinemic RIIIS/J Mice1

S. Higgs, P. Christadoss, E. Goluszko, 2004, The Journal of Immunology.

Mice Gravis in Hypogammaglobulinemic RIIIS / J Severity of Antibody-Mediated Myasthenia Circulating Immune Complexes Augment

S. Higgs, P. Christadoss, E. Goluszko, 2004 .

Possible Linkage of Myasthenia Gravis Susceptibility in R111 S/J Mice to a Genomic Deletion of T Cell Receptor Vβ Genes

M. Shenoy, P. Christadoss, R. Kaul, 1994 .

A new mouse model of autoimmune ocular myasthenia gravis.

W. Allman, S. Higgs, P. Christadoss, 2007, Investigative ophthalmology & visual science.

IFN-α Therapy Is Effective in Suppressing the Clinical Experimental Myasthenia Gravis

P. Christadoss, S. Baron, E. Goluszko, 1996 .